Jiangxi Biosyn Healthy Pharma Co., Ltd., established in 2008 in Jiangxi Province, China, is a key manufacturing base of Jinyao Pharmaceutical Co., Ltd. (Stock Code: 600488.SH), specializing in steroid hormones and pharmaceutical intermediates, with a total investment of RMB 150 million.Covering an area of 68,701 square meters, the company operates integrated production facilities, including chemical synthesis and fermentation plants, GMP-compliant manufacturing facilities, a quality control and testing center, and an R&D center. Equipped with more than 100 synthesis and fermentation tanks, the company has an annual production capacity exceeding 150 metric tons.Our core product portfolio includes drospirenone, eplerenone, mifepristone, and estrogen product series, serving the pharmaceutical industry with reliable manufacturing capabilities and a focus on quality.In 2014, Tianjin Tianyao Pharmaceutical Co., Ltd. became a shareholder of the company, further strengthening its industrial resources and technical foundation. As a major player in Asia's steroid hormone industry, Tianjin Tianyao Pharmaceutical Co., Ltd. is a state-owned, A-share-listed pharmaceutical company listed on the Shanghai Stock Exchange in 1999.Leveraging strong manufacturing infrastructure, technical expertise, and industry partnerships, Jiangxi Biosyn Healthy Pharma Co., Ltd. is committed to the development and production of steroid hormones and pharmaceutical intermediates for global pharmaceutical markets. More >